SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report
SCLC is frequently associated with paraneoplastic syndromes, including dermatomyositis. Patients with malignancy-associated dermatomyositis express a specific autoantibody pattern usually positive for anti–transcription intermediary factor 1-γ (TIF1-γ), suggesting anti–TIF1-γ plays a role in develop...
Main Authors: | Johnathan Arnon, MD, Anna Elia, MD, Yuval Nevo, PhD, Alexander Lossos, MD, Hovav Nechushtan, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | JTO Clinical and Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266636432100076X |
Similar Items
-
Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis
by: Yorihisa Kotobuki, et al.
Published: (2021-01-01) -
Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature
by: Ryohei Ono, et al.
Published: (2021-03-01) -
Identification des fonctions oncosuppressives de TIF1γ (Transcriptional Intermediary Factor 1 γ)
by: Pommier, Roxane
Published: (2014) -
First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome
by: B. Palterer, et al.
Published: (2017-08-01) -
Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report
by: Chikako Shibata, et al.
Published: (2019-06-01)